Golden Throat Holdings Group Company Limited's latest marketcap:
As of 06/17/2025, Golden Throat Holdings Group Company Limited's market capitalization has reached $427.41 M. According to our data, Golden Throat Holdings Group Company Limited is the 14895th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 427.41 M |
| Revenue (ttm) | 160.58 M |
| Net Income (ttm) | 43.18 M |
| Shares Out | 739.3 M |
| EPS (ttm) | 0.06 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 06/16/2025 |
| Earnings Date | 05/27/2025 |
Golden Throat Holdings Group Company Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/17/2025 | HK$427.41 M | 58.02% | 14895 |
| 12/31/2024 | HK$2.4 B | -3.28% | 16241 |
| 12/29/2023 | HK$2.48 B | 75.39% | 16084 |
| 12/30/2022 | HK$1.41 B | 20.89% | 18636 |
| 12/31/2021 | HK$1.17 B | 18.8% | 20557 |
| 12/31/2020 | HK$983.27 M | 11.76% | 19258 |
| 12/31/2019 | HK$879.77 M | -5.56% | 17506 |
| 12/31/2018 | HK$931.52 M | -35.05% | 16381 |
| 12/29/2017 | HK$1.43 B | -35.33% | 14987 |
| 12/30/2016 | HK$2.22 B | -33.77% | 11400 |
Company Profile
About Golden Throat Holdings Group Company Limited
Golden Throat Holdings Group Company Limited is an investment holding company specializing in the manufacture and sale of pharmaceutical, healthcare food, and related products. Headquartered in Liuzhou, China, the company has been operating since 1956 and serves both domestic and international markets.
Key Products
- Golden Throat Lozenges: An over-the-counter medicine designed to relieve sore and dry throat symptoms, as well as hoarse voice caused by acute pharyngitis.
- Golden Throat Lozenge Series: Includes Dule Lozenges, sugar-free Dule Lozenges, and other sugar-free flavors such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn.
- Yinxingye Tablets: A product aimed at improving blood circulation, removing blood stasis, and enhancing energy channel function.
- Golden Throat Intestinal Series: A line of digestive health products.
- Golden Throat Compound Probiotic Lozenges: Designed to support throat and immune health.
Global Reach
The company exports its products to multiple regions, including:
- United States
- Canada
- Japan
- European Union
- Australia
- Southeast Asia
- Middle East
- Mexico
- Africa
Golden Throat Holdings Group Company Limited continues to expand its presence in the pharmaceutical and healthcare sectors, delivering high-quality products to consumers worldwide.
Frequently Asked Questions
-
What is Golden Throat Holdings Group Company Limited's (HKG-6896) current market cap?As of 06/17/2025, Golden Throat Holdings Group Company Limited (including the parent company, if applicable) has an estimated market capitalization of $427.41 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Golden Throat Holdings Group Company Limited (HKG-6896) rank globally by market cap?Golden Throat Holdings Group Company Limited global market capitalization ranking is approximately 14895 as of 06/17/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.